Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

Erbitux

The Top Pharma List's top 50 pharmaceutical products by global sales ranking is compiled from GlobalData's pharmaceutical revenue figures. Erbitux was produced by Merck & Co. and Bristol-Myers Squibb.

Lilly buys Armo for $1.6bn to bolster immuno-oncology pipeline

Lilly buys Armo for $1.6bn to bolster immuno-oncology pipeline

It also sells gastrointestinal cancer antibodies Erbitux (cetuximab) and recently launched Cyramza (ramucirumab).

Merck, Pfizer cue up first EU launches for PD-L1 drug Bavencio

Merck, Pfizer cue up first EU launches for PD-L1 drug Bavencio it introduced colorectal and head and neck cancer therapy Erbitux (cetuximab) more than a decade ago.

NICE expands Merck KGaA’s Erbitux reach

NICE expands Merck KGaA’s Erbitux reach Backs the medicines use for patients with SCCHN. After several attempts, Merck KgAa has finally persuaded the UK medicines cost-effectiveness watchdog to back its monoclonal antibody Erbitux (cetuximab), for use ... access to Erbitux and that NICE has

Can NICE deliver on its funding promises?

Can NICE deliver on its funding promises? Moreover, while no product has yet received a negative final decision, draft ‘no’s for Kadcyla, Adcetris and Erbitux will have put Roche, Takeda and Merck KGaA on notice.

Trials of AZ's durvalumab restart as FDA hold is relaxed

Trials of AZ's durvalumab restart as FDA hold is relaxed KESTREL is comparing durvalumab and tremelimumab in combination or durvalumab monotherapy to Eli Lilly's Erbitux (cetuximab) plus chemotherapy, while EAGLE is comparing the same two AZ regimens with the standard

1 2 3 4 5 6 7 8 9 10 [ Next 5 results ]

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Blue Latitude Health

Blue Latitude Health is a creative marketing consultancy. Founded in 2003, our combination of heritage, approach and capability gives us...

Latest intelligence

Brain power: fresh approaches to Alzheimer’s drug discovery
New alliances are learning from past mistakes and breaking down research barriers...
Genomics integration: can the NHS rise to the challenge?
Experts gather to discuss the UK’s genomic landscape...
London
“Brexit has been a catalyst for UK clinical research... it’s turbocharged change”
The UK clinical trials environment has been transformed in recent years – but can it really buck Brexit’s risks and uncertainties?...

Infographics